{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T15:34:42Z","timestamp":1784129682951,"version":"3.55.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T00:00:00Z","timestamp":1707868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T00:00:00Z","timestamp":1707868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Rapid-deployment aortic valve replacement (RDAVR) is an alternative to conventional AVR (cAVR) for aortic stenosis. Benefits include a reduction in operative times, facilitation of minimal access surgery and superior haemodynamics compared to conventional valves. However, further evidence is required to inform guidelines, preferably in the form of propensity-matched studies that include mid-term follow-up data.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This was a single-centre, retrospective, propensity-matched cohort study comparing the Perceval and conventional Perimount Magna Ease valve for short- and mid-term clinical parameters and size-matched mid-term echocardiographic parameters (<jats:italic>n<\/jats:italic>\u2009=\u2009102 in both groups) from 2014 to 2020. Data were extracted from a nationally managed dataset.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>There were no demographic differences between the matched groups. The Perceval group had shorter cross-clamp time (Perceval 62 [49\u201381] minutes; Perimount 79 [63\u2013102] minutes, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), shorter bypass time (Perceval 89 [74\u2013114] minutes; Perimount 104 [84\u2013137] minutes, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), and more frequent minimally-invasive approaches (Perceval 28%; Perimount 5%, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). Size-matched haemodynamics showed initially higher gradients in the Perceval group, but haemodynamics equalised at 12\u2009+\u2009months. The Perceval group had a more favourable % change in the left ventricular posterior wall dimension at 2\u2009+\u2009years (Perceval \u2212\u20094.8\u2009\u00b1\u200918; Perimount 17\u2009\u00b1\u20092).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The Perceval facilitated shorter operations, which may benefit intermediate-high-risk, elderly patients with comorbidities requiring concomitant procedures. It also facilitated minimally invasive surgery. Size-matched haemodynamic performance was similar at mid-term follow-up, with the Perceval possibly better facilitating regression of left ventricular hypertrophy.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13019-024-02575-4","type":"journal-article","created":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T11:02:18Z","timestamp":1707908538000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Perceval sutureless bioprosthesis versus Perimount sutured bioprosthesis for aortic valve replacement in patients with aortic stenosis: a retrospective, propensity-matched study"],"prefix":"10.1186","volume":"19","author":[{"given":"Sharan J","family":"Kapadia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Yousuf","family":"Salmasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicja","family":"Zientara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Roussin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesare","family":"Quarto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Asimakopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,14]]},"reference":[{"issue":"36","key":"2575_CR1","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1093\/eurheartj\/ehx391","volume":"38","author":"H Baumgartner","year":"2017","unstructured":"Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, et al. 2017 ESC\/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2017;38(36):2739\u201391. https:\/\/doi.org\/10.1093\/eurheartj\/ehx391.","journal-title":"Eur Heart J"},{"issue":"8","key":"2575_CR2","doi-asserted-by":"publisher","first-page":"e005251","DOI":"10.1161\/JAHA.116.005251","volume":"6","author":"M Dal\u00e9n","year":"2017","unstructured":"Dal\u00e9n M, Sartipy U, Cederlund K, Franco-Cereceda A, Svensson A, Themudo R, et al. Hypo\u2010attenuated leaflet thickening and reduced leaflet motion in sutureless bioprosthetic aortic valves. J Am Heart Association. 2017;6(8):e005251. https:\/\/doi.org\/10.1161\/JAHA.116.005251.","journal-title":"J Am Heart Association"},{"issue":"3","key":"2575_CR3","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/jocs.16223","volume":"37","author":"MY Salmasi","year":"2022","unstructured":"Salmasi MY, Ramaraju S, Haq I, Mohamed RAB, Khan T, Oezalp F, et al. Rapid deployment technology versus conventional sutured bioprostheses in aortic valve replacement. J Card Surg. 2022;37(3):640\u201355. https:\/\/doi.org\/10.1111\/jocs.16223.","journal-title":"J Card Surg"},{"issue":"13","key":"2575_CR4","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/j.jacc.2018.01.065","volume":"71","author":"S Ensminger","year":"2018","unstructured":"Ensminger S, Fujita B, Bauer T, M\u00f6llmann H, Beckmann A, Bekeredjian R, et al. Rapid deployment versus conventional bioprosthetic valve replacement for aortic stenosis. J Am Coll Cardiol. 2018;71(13):1417\u201328. https:\/\/doi.org\/10.1016\/j.jacc.2018.01.065.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2575_CR5","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13019-016-0438-7","volume":"11","author":"P Dedeilias","year":"2016","unstructured":"Dedeilias P, Baikoussis NG, Prappa E, Asvestas D, Argiriou M, Charitos C. Aortic valve replacement in elderly with small aortic root and low body surface area; the Perceval S valve and its impact in effective orifice area. J Cardiothorac Surg. 2016;11(1):54. https:\/\/doi.org\/10.1186\/s13019-016-0438-7.","journal-title":"J Cardiothorac Surg"},{"issue":"3","key":"2575_CR6","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1093\/ejcts\/ezv369","volume":"49","author":"B Gersak","year":"2016","unstructured":"Gersak B, Fischlein T, Folliguet TA, Meuris B, Teoh KHT, Moten SC, et al. Sutureless, rapid deployment valves and stented bioprosthesis in aortic valve replacement: recommendations of an International Expert Consensus Panel. Eur J Cardiothorac Surg. 2016;49(3):709\u201318. https:\/\/doi.org\/10.1093\/ejcts\/ezv369.","journal-title":"Eur J Cardiothorac Surg"},{"key":"2575_CR7","unstructured":"Overview | Sutureless aortic valve replacement for aortic stenosis | Guidance | NICEhttps:\/\/www.nice.org.uk\/guidance\/ipg624."},{"issue":"3","key":"2575_CR8","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.jtcvs.2020.11.162","volume":"161","author":"T Fischlein","year":"2021","unstructured":"Fischlein T, Folliguet T, Meuris B, Shrestha ML, Roselli EE, McGlothlin A, et al. Sutureless versus conventional bioprostheses for aortic valve replacement in severe symptomatic aortic valve stenosis. J Thorac Cardiovasc Surg. 2021;161(3):920\u201332. https:\/\/doi.org\/10.1016\/j.jtcvs.2020.11.162.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"2575_CR9","doi-asserted-by":"publisher","first-page":"e006091","DOI":"10.1161\/JAHA.117.006091","volume":"7","author":"M Meco","year":"2018","unstructured":"Meco M, Montisci A, Miceli A, Panisi P, Donatelli F, Cirri S, et al. Sutureless perceval aortic valve versus conventional stented bioprostheses: meta-analysis of postoperative and midterm results in isolated aortic valve replacement. J Am Heart Association. 2018;7(4):e006091. https:\/\/doi.org\/10.1161\/JAHA.117.006091.","journal-title":"J Am Heart Association"},{"key":"2575_CR10","doi-asserted-by":"crossref","unstructured":"Mariani C, Murana G, Botta L, Gliozzi G, Folesani G, Santamaria V, et al. Single centre experience in 1202 biological prosthesis: a comparison between sutured, sutureless and surgical transcatheter aortic valve. Eur Heart J. 2021;42.ehab724.2259.","DOI":"10.1093\/eurheartj\/ehab724.2259"},{"issue":"6","key":"2575_CR11","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1016\/j.jtcvs.2015.08.052","volume":"150","author":"C Muneretto","year":"2015","unstructured":"Muneretto C, Alfieri O, Cesana BM, Bisleri G, De Bonis M, Di Bartolomeo R, et al. A comparison of conventional surgery, transcatheter aortic valve replacement, and sutureless valves in real-world patients with aortic stenosis and intermediate- to high-risk profile. J Thorac Cardiovasc Surg. 2015;150(6):1570\u20139. https:\/\/doi.org\/10.1016\/j.jtcvs.2015.08.052.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"2575_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.14503\/THIJ-16-6092","volume":"45","author":"MO Hanedan","year":"2018","unstructured":"Hanedan MO, Yuruk MA, Parlar AI, Ziyrek U, Arslan AK, Sayar U, et al. Sutureless versus conventional aortic valve replacement: outcomes in 70 high-risk patients undergoing concomitant cardiac procedures. Tex Heart Inst J. 2018;45(1):11\u20136. https:\/\/doi.org\/10.14503\/THIJ-16-6092.","journal-title":"Tex Heart Inst J"},{"issue":"2","key":"2575_CR13","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.athoracsur.2021.03.048","volume":"113","author":"KY Lam","year":"2022","unstructured":"Lam KY, Reardon MJ, Yakubov SJ, Modine T, Fremes S, Tonino PAL, et al. Surgical sutureless and sutured aortic valve replacement in low-risk patients. Ann Thorac Surg. 2022;113(2):616\u201322. https:\/\/doi.org\/10.1016\/j.athoracsur.2021.03.048.","journal-title":"Ann Thorac Surg"},{"key":"2575_CR14","doi-asserted-by":"publisher","unstructured":"Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP, Gentile F, et al. 2020 ACC\/AHA Guideline for the management of patients with Valvular Heart Disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice guidelines. Circulation. 2021;143(5). https:\/\/doi.org\/10.1161\/CIR.0000000000000923.","DOI":"10.1161\/CIR.0000000000000923"},{"key":"2575_CR15","doi-asserted-by":"crossref","unstructured":"Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, et al. 2021 ESC\/EACTS guidelines for the management of valvular heart disease. Oxford University Press (OUP); 2021.","DOI":"10.1093\/ejcts\/ezac209"},{"issue":"6","key":"2575_CR16","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1053\/j.jvca.2008.08.004","volume":"22","author":"S Salis","year":"2008","unstructured":"Salis S, Mazzanti VV, Merli G, Salvi L, Tedesco CC, Veglia F, et al. Cardiopulmonary bypass duration is an independent predictor of morbidity and mortality after cardiac surgery. J Cardiothorac Vasc Anesth. 2008;22(6):814\u201322. https:\/\/doi.org\/10.1053\/j.jvca.2008.08.004.","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"1","key":"2575_CR17","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1186\/s13019-021-01739-w","volume":"16","author":"MY Salmasi","year":"2021","unstructured":"Salmasi MY, Papa K, Mozalbat D, Ashraf M, Zientara A, Chauhan I, et al. Converging rapid deployment prostheses with minimal access surgery: analysis of early outcomes. J Cardiothorac Surg. 2021;16(1):355. https:\/\/doi.org\/10.1186\/s13019-021-01739-w.","journal-title":"J Cardiothorac Surg"},{"key":"2575_CR18","doi-asserted-by":"publisher","unstructured":"Fischlein T, Caporali E, Asch FM, Vogt F, Pollari F, Folliguet T, et al. Hemodynamic performance of sutureless vs. conventional bioprostheses for aortic valve replacement: the 1-year core-lab results of the randomized persist-avr trial. Front Cardiovasc Med. 2022;9. https:\/\/doi.org\/10.3389\/fcvm.2022.844876. https:\/\/www.frontiersin.org\/articles\/.","DOI":"10.3389\/fcvm.2022.844876"},{"key":"2575_CR19","doi-asserted-by":"crossref","unstructured":"Kueri S, Berger T, Puiu P, Alhamami Y, Diab N, Czerny M, et al. The hemodynamic performance of the Perceval Sutureless Aortic Valve in a propensity-matched comparison to the Carpentier\u2013Edwards Perimount and Perimount magna ease valves for aortic valve replacement. Georg Thieme Verlag KG; 2022.","DOI":"10.1055\/s-0042-1755207"},{"issue":"6","key":"2575_CR20","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1016\/j.jtcvs.2018.01.084","volume":"155","author":"SH Sohn","year":"2018","unstructured":"Sohn SH, Jang M, Hwang HY, Kim KH. Rapid deployment or sutureless versus conventional bioprosthetic aortic valve replacement: a meta-analysis. J Thorac Cardiovasc Surg. 2018;155(6):2402\u20132412e5. https:\/\/doi.org\/10.1016\/j.jtcvs.2018.01.084.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"2575_CR21","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1093\/icvts\/ivt362","volume":"18","author":"G Santarpino","year":"2014","unstructured":"Santarpino G, Pfeiffer S, Pollari F, Concistr\u00e8 G, Vogt F, Fischlein T. Left ventricular mass regression after sutureless implantation of the Perceval S aortic valve bioprosthesis: preliminary results. Interact Cardiovasc Thorac Surg. 2014;18(1):38\u201342. https:\/\/doi.org\/10.1093\/icvts\/ivt362.","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"2575_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2023.01.017","author":"GS Aldea","year":"2023","unstructured":"Aldea GS, Burke CR, Fischlein T, Heimansohn DA, Haverich A, Suri RM, et al. Does valve size impact hemodynamic, left ventricular mass regression, and prosthetic valve deterioration with a sutureless aortic valve? J Thorac Cardiovasc Surg. 2023. https:\/\/doi.org\/10.1016\/j.jtcvs.2023.01.017.","journal-title":"J Thorac Cardiovasc Surg"}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-024-02575-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13019-024-02575-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-024-02575-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T11:06:58Z","timestamp":1707908818000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiothoracicsurgery.biomedcentral.com\/articles\/10.1186\/s13019-024-02575-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,14]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2575"],"URL":"https:\/\/doi.org\/10.1186\/s13019-024-02575-4","relation":{},"ISSN":["1749-8090"],"issn-type":[{"value":"1749-8090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,14]]},"assertion":[{"value":"16 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The need for ethical approval was waived by the research and ethics office at Royal Brompton and Harefield Trust, given the retrospective nature of this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"George Asimakopoulos is a proctor for Perceval.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"95"}}